Teva Sells Slate of Women's Health Products

Teva Pharmaceutical Industries Ltd. will sell the remaining assets in its specialty global women’s health business for $1.38 billion, the company’s latest move to grapple with high debt.

from WSJ.com: US Business http://ift.tt/2wBtHvs
via IFTTT